Vanda Pharmaceuticals Ownership | Who Owns Vanda Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Vanda Pharmaceuticals Ownership Summary


Vanda Pharmaceuticals is owned by 4.03% institutional investors, 6.65% insiders, and 89.31% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 15.63% of VNDA shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.99% of its assets in Vanda Pharmaceuticals shares.

VNDA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVanda Pharmaceuticals4.03%6.65%89.31%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de9.10M15.63%$43.61M
Blackrock8.14M14.09%$45.98M
Renaissance3.85M6.61%$18.46M
Vanguard group3.51M6.02%$16.80M
Dimensional fund advisors lp2.49M4.27%$11.92M
Tang capital management2.35M4.04%$11.27M
Millennium management2.14M3.66%$9.82M
Acadian asset management1.90M3.26%$9.10M
Jacobs levy equity management1.49M2.57%$8.40M
Geode capital management1.45M2.49%$6.95M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Krensavage asset management662.17K1.72%$3.74M
Profit investment management329.82K1.27%$1.58M
Tang capital management2.35M0.75%$11.27M
Monaco asset management sam392.26K0.27%$1.88M
Clearalpha technologies lp60.00K0.17%$275.40K
Stonepine capital management25.00K0.10%$119.75K
Empire financial management company64.00K0.10%$306.56K
One68 global capital26.06K0.06%$119.61K
Gsa capital partners llp138.42K0.05%$663.00K
Jacobs levy equity management1.49M0.03%$8.40M

Top Buyers

HolderShares% AssetsChange
Millennium management2.14M0.01%1.47M
Krensavage asset management662.17K1.72%662.17K
Blackrock funding, inc. /de9.10M0.00%508.60K
Schonfeld strategic advisors270.54K0.01%270.54K
Susquehanna fundamental investments254.84K0.02%254.84K

Top Sellers

HolderShares% AssetsChange
Nantahala capital management---1.59M
Bank of america corp /de/77.42K--1.13M
Morgan stanley497.22K0.00%-1.01M
Assenagon asset management---730.82K
Apg asset management---371.90K

New Positions

HolderShares% AssetsChangeValue
Krensavage asset management662.17K1.72%662.17K$3.74M
Schonfeld strategic advisors270.54K0.01%270.54K$1.30M
Susquehanna fundamental investments254.84K0.02%254.84K$1.22M
Norges bank115.00K0.00%115.00K$550.85K
Empire financial management company64.00K0.10%64.00K$306.56K

Sold Out

HolderChange
National bank of canada /fi/-2.00
Srs capital advisors-9.00
Nelson, van denburg & campbell wealth management group-10.00
Gps wealth strategies group-25.00
Assetmark-31.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20254-97.33%2,360,082-94.49%40.07%3-95.95%--100.00%
Dec 31, 2024140-11.39%41,400,330-5.62%711.25%71-2.74%39-23.53%
Sep 30, 20241581.94%43,866,8090.75%751.32%73-14.12%5110.87%
Jun 30, 20241534.79%43,538,769-9.37%751.09%8329.69%46-20.69%
Mar 31, 2024146-8.18%48,037,922-4.96%831.08%64-20.99%585.45%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.74M2.99%-
Vanguard Total Stock Mkt Idx Inv1.74M2.96%-
iShares Russell 2000 ETF1.44M2.45%708.00
BlackRock Advantage Small Cap Core Instl1.06M1.79%212.10K
Vanguard Institutional Extnd Mkt Idx Tr896.83K1.52%-1.60K
Federated Hermes MDT Small Cap Core IS624.55K1.07%-
Federated Hermes MDT SCC Institutional624.55K1.06%-
Fidelity Small Cap Index563.62K0.97%-
Nuveen Quant Small Cap Equity R6530.50K0.91%166.10K
iShares Russell 2000 Value ETF503.99K0.86%-

Recent Insider Transactions


DateNameRoleActivityValue
May 21, 2025Polymeropoulos Mihael Hristos President and CEOBuy$41.88K
May 21, 2025Polymeropoulos Mihael Hristos President and CEOBuy$2.11K
May 16, 2025Polymeropoulos Mihael Hristos President and CEOBuy$84.47K
Mar 06, 2025Polymeropoulos Mihael Hristos President and CEOBuy$25.05K
Mar 06, 2025Polymeropoulos Mihael Hristos President and CEOBuy$25.10K

Insider Transactions Trends


DateBuySell
2025 Q23-
2025 Q111-
2024 Q4-1
2024 Q3-1
2024 Q2--

VNDA Ownership FAQ


Who Owns Vanda Pharmaceuticals?

Vanda Pharmaceuticals shareholders are primarily institutional investors at 4.03%, followed by 6.65% insiders and 89.32% retail investors. The average institutional ownership in Vanda Pharmaceuticals's industry, Biotech Stocks , is 63.96%, which Vanda Pharmaceuticals falls below.

Who owns the most shares of Vanda Pharmaceuticals?

Vanda Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (9.1M shares, 15.63%), Blackrock (8.14M shares, 14.09%), and Renaissance (3.85M shares, 6.61%). Together, they hold 36.33% of Vanda Pharmaceuticals’s total shares outstanding.

Does Blackrock own Vanda Pharmaceuticals?

Yes, BlackRock owns 14.09% of Vanda Pharmaceuticals, totaling 8.14M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 45.98M$. In the last quarter, BlackRock decreased its holdings by -1.629K shares, a -0.02% change.

Who is Vanda Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is Vanda Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 1.72% of its assets in 662.17K Vanda Pharmaceuticals shares, valued at 3.74M$.

Who is the top mutual fund holder of Vanda Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Vanda Pharmaceuticals shares, with 2.99% of its total shares outstanding invested in 1.74M Vanda Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools